ALT
Price
$3.71
Change
-$0.07 (-1.85%)
Updated
Sep 8 closing price
Capitalization
327.43M
63 days until earnings call
INDP
Price
$2.91
Change
-$0.39 (-11.82%)
Updated
Sep 8 closing price
Capitalization
3.1M
Interact to see
Advertisement

ALT vs INDP

Header iconALT vs INDP Comparison
Open Charts ALT vs INDPBanner chart's image
Altimmune
Price$3.71
Change-$0.07 (-1.85%)
Volume$1.51M
Capitalization327.43M
Indaptus Therapeutics
Price$2.91
Change-$0.39 (-11.82%)
Volume$985.74K
Capitalization3.1M
ALT vs INDP Comparison Chart in %
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. INDP commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Hold and INDP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (ALT: $3.71 vs. INDP: $3.30)
Brand notoriety: ALT and INDP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 47% vs. INDP: 754%
Market capitalization -- ALT: $327.43M vs. INDP: $3.1M
ALT [@Biotechnology] is valued at $327.43M. INDP’s [@Biotechnology] market capitalization is $3.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileINDP’s FA Score has 1 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • INDP’s FA Score: 1 green, 4 red.
According to our system of comparison, INDP is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 4 TA indicator(s) are bullish while INDP’s TA Score has 4 bullish TA indicator(s).

  • ALT’s TA Score: 4 bullish, 3 bearish.
  • INDP’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ALT is a better buy in the short-term than INDP.

Price Growth

ALT (@Biotechnology) experienced а -3.13% price change this week, while INDP (@Biotechnology) price change was -49.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.17%. For the same industry, the average monthly price growth was +16.92%, and the average quarterly price growth was +32.81%.

Reported Earning Dates

ALT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALT($327M) has a higher market cap than INDP($3.1M). ALT YTD gains are higher at: -48.544 vs. INDP (-88.125). INDP has higher annual earnings (EBITDA): -16.34M vs. ALT (-88.03M). ALT has more cash in the bank: 183M vs. INDP (6.16M). INDP has less debt than ALT: INDP (6.54M) vs ALT (15.8M). ALT has higher revenues than INDP: ALT (20K) vs INDP (0).
ALTINDPALT / INDP
Capitalization327M3.1M10,555%
EBITDA-88.03M-16.34M539%
Gain YTD-48.544-88.12555%
P/E RatioN/AN/A-
Revenue20K0-
Total Cash183M6.16M2,972%
Total Debt15.8M6.54M242%
FUNDAMENTALS RATINGS
ALT vs INDP: Fundamental Ratings
ALT
INDP
OUTLOOK RATING
1..100
1050
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
32
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6598
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INDP's Valuation (32) in the null industry is somewhat better than the same rating for ALT (97) in the Miscellaneous Commercial Services industry. This means that INDP’s stock grew somewhat faster than ALT’s over the last 12 months.

INDP's Profit vs Risk Rating (100) in the null industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that INDP’s stock grew similarly to ALT’s over the last 12 months.

ALT's SMR Rating (98) in the Miscellaneous Commercial Services industry is in the same range as INDP (100) in the null industry. This means that ALT’s stock grew similarly to INDP’s over the last 12 months.

ALT's Price Growth Rating (65) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for INDP (98) in the null industry. This means that ALT’s stock grew somewhat faster than INDP’s over the last 12 months.

ALT's P/E Growth Rating (100) in the Miscellaneous Commercial Services industry is in the same range as INDP (100) in the null industry. This means that ALT’s stock grew similarly to INDP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTINDP
RSI
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 5 days ago
86%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 27 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMPO19.400.90
+4.86%
CompoSecure
MOV19.320.20
+1.05%
Movado Group
PZG1.050.01
+0.96%
Paramount Gold Nevada Corp
BZ23.94-0.03
-0.15%
Kanzhun Limited
APDN2.31-0.09
-3.56%
Applied DNA Sciences Inc

INDP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INDP has been loosely correlated with UNCY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INDP jumps, then UNCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDP
1D Price
Change %
INDP100%
-15.23%
UNCY - INDP
53%
Loosely correlated
+0.23%
ALT - INDP
45%
Loosely correlated
-1.85%
CDTX - INDP
38%
Loosely correlated
-1.61%
IMAB - INDP
38%
Loosely correlated
-2.51%
RVPH - INDP
30%
Poorly correlated
+2.16%
More